The third question of the series is “Are you proactive regarding your patients’ possible comorbidities?” In particular, the doctors consider patient characteristics such as age, performance status, and other health problems. They talk about when to consider stem cell transplant with frailer patients. 

IMWG Myeloma Experts debate the latest trends in treatment
June 9, 2016
Copenhagen, Denmark

Previous Post
ICER blinks and patients benefit
Next Post
Robin Tuohy's testimony at CEPAC on Treatment Options for Relapsed and Refractory Myeloma.

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.